These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 23335809)

  • 21. Evaluation of germline PTEN mutations in endometrial cancer patients.
    Black D; Bogomolniy F; Robson ME; Offit K; Barakat RR; Boyd J
    Gynecol Oncol; 2005 Jan; 96(1):21-4. PubMed ID: 15589575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
    Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
    J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid Pathology Findings in Cowden Syndrome: A Clue for the Diagnosis of the PTEN Hamartoma Tumor Syndrome.
    Cameselle-Teijeiro J; Fachal C; Cabezas-Agrícola JM; Alfonsín-Barreiro N; Abdulkader I; Vega-Gliemmo A; Hermo JA
    Am J Clin Pathol; 2015 Aug; 144(2):322-8. PubMed ID: 26185318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome.
    Smith JR; Marqusee E; Webb S; Nose V; Fishman SJ; Shamberger RC; Frates MC; Huang SA
    J Clin Endocrinol Metab; 2011 Jan; 96(1):34-7. PubMed ID: 20962022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
    Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
    J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
    Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
    Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
    Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The microbiome in
    Byrd V; Getz T; Padmanabhan R; Arora H; Eng C
    Endocr Relat Cancer; 2018 Mar; 25(3):233-243. PubMed ID: 29233840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
    Pilarski R; Burt R; Kohlman W; Pho L; Shannon KM; Swisher E
    J Natl Cancer Inst; 2013 Nov; 105(21):1607-16. PubMed ID: 24136893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer.
    Tate G; Suzuki T; Endo Y; Mitsuya T
    Cancer Genet Cytogenet; 2008 Jul; 184(1):67-71. PubMed ID: 18558293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel dermatological and skeletal features associated with PTEN variant in PTEN hamartoma tumor syndrome.
    Comeau D; Allain V; Maillet-Lebel N; Ben Amor M
    Eur J Med Genet; 2023 Aug; 66(8):104798. PubMed ID: 37307869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
    Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
    Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.
    Hendricks LAJ; Hoogerbrugge N; Venselaar H; Aretz S; Spier I; Legius E; Brems H; de Putter R; Claes KBM; Evans DG; Woodward ER; Genuardi M; Brugnoletti F; van Ierland Y; Dijke K; Tham E; Tesi B; Schuurs-Hoeijmakers JHM; Branchaud M; Salvador H; Jahn A; Schnaiter S; Anastasiadou VC; Brunet J; Oliveira C; Roht L; Blatnik A; Irmejs A; ; Mensenkamp AR; Vos JR
    Eur J Med Genet; 2022 Dec; 65(12):104632. PubMed ID: 36270489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.
    Smith JR; Liu E; Church AJ; Asch E; Cherella CE; Srivastava S; Kamihara J; Wassner AJ
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1121-e1130. PubMed ID: 33347563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes.
    Henderson CJ; Ngeow J; Collins MH; Martin LJ; Putnam PE; Abonia JP; Marsolo K; Eng C; Rothenberg ME
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):553-60. PubMed ID: 24345843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?
    Yehia L; Eng C
    Hum Mol Genet; 2020 Oct; 29(R2):R150-R157. PubMed ID: 32568377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome.
    Sloot YJE; Rabold K; Netea MG; Smit JWA; Hoogerbrugge N; Netea-Maier RT
    Oncogene; 2019 May; 38(19):3743-3755. PubMed ID: 30670777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers.
    Won HS; Chang ED; Na SJ; Whang IY; Lee DS; You SH; Kim YS; Kim JS
    Cancer Res Treat; 2019 Jan; 51(1):402-407. PubMed ID: 29510612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
    Ngeow J; Eng C
    Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with PTEN hamartoma tumor syndrome.
    Liu D; Yehia L; Dhawan A; Ni Y; Eng C
    Cell Rep Med; 2024 Feb; 5(2):101384. PubMed ID: 38242121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.